Compounds > testosterone 4-n-butylcyclohexylcarboxylate
Page last updated: 2024-09-02

testosterone 4-n-butylcyclohexylcarboxylate and Hypogonadism

testosterone 4-n-butylcyclohexylcarboxylate has been researched along with Hypogonadism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Behre, HM; Dressendörfer, RA; Nieschlag, E; Strasburger, CJ; Tschöp, M1
Behre, HM; Nieschlag, E1

Trials

2 trial(s) available for testosterone 4-n-butylcyclohexylcarboxylate and Hypogonadism

ArticleYear
A time-resolved fluorescence immunoassay for the measurement of testosterone in saliva: monitoring of testosterone replacement therapy with testosterone buciclate.
    Clinical chemistry and laboratory medicine, 1998, Volume: 36, Issue:4

    Topics: Adult; Dihydrotestosterone; Estradiol; Female; Fluoroimmunoassay; Humans; Hypogonadism; Male; Middle Aged; Radioimmunoassay; Saliva; Sensitivity and Specificity; Sex Hormone-Binding Globulin; Testosterone

1998
Testosterone buciclate (20 Aet-1) in hypogonadal men: pharmacokinetics and pharmacodynamics of the new long-acting androgen ester.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 75, Issue:5

    Topics: Adult; Androgens; Blood Pressure; Body Weight; Erythropoiesis; Estrogens; Gonadotropins; Hematocrit; Humans; Hypogonadism; Male; Middle Aged; Prostate; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone; Ultrasonography

1992